1. Inicio
  2. Proyectos y Estudios Clínicos
  3. Contratos Miguel Servet Tipo II

Contratos Miguel Servet Tipo II

Datos básicos

Código:
CPII21/00004
Dotación:
101.250,00 €
Año Inicial:
2022
Año final:
2024
PROYECTO Contrato laboral NACIONAL Subvención

Objetivos del proyecto

Contrato Miguel Servet Tipo II de Raquel López Mejías

Unidades de investigación

Documentos

  • No hay documentos

Participantes

Financiadores

INSTITUTO DE SALUD CARLOS III.

Resultados del Proyecto

CHARACTERIZING THE PRE-DISEASE STATE OF PSORIATIC ARTHRITIS: CXCL10 LEVELS ARE ASSOCIATED WITH SUBCLINICAL SYNOVITIS IN PATIENTS WITH PSORIASIS

Meeting Abstract. 10.1136/annrheumdis-2023-eular.5466. 2023

  • Open Access.

ENDOTHELIN-1 AS A POTENTIAL CANDIDATE TO SHED LIGHT ON THE CHALLENGE OF INTERSTITIAL LUNG DISEASE DIAGNOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Meeting Abstract. 10.1136/annrheumdis-2023-eular.2007. 2023

  • Open Access.

IGAV AND IGAN: A SINGLE ENTITY REGARDING CD40, BLK AND BANK1 POLYMORPHISMS

Meeting Abstract. 2023


Increase of Serum Endothelin-1 Levels in Patients with Interstitial Lung Disease Associated with Autoimmune Diseases

Meeting Abstract. 2022


MUCOSAL IMMUNE DEFENCE POLYMORPHISMS: RELEVANT PLAYERS IN IGA VASCULITIS?

Meeting Abstract. 10.1136/annrheumdis-2023-eular.73. 2023

  • Open Access.

Nuclear Factor of Activated T Cells Cytoplasmic 1 as a Potential Biomarker of Increased Cardiovascular Risk in Patients with Early Rheumatoid Arthritis

Meeting Abstract. 2022


PLEUROPARENCHYMAL FIBROELASTOSIS: A SPECIAL CLINICAL SITUATION IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASES. DESCRIPTIVE STUDY FROM A REFERRAL CENTRE

Meeting Abstract. 10.1136/annrheumdis-2023-eular.1387. 2023

  • Open Access.

Compartir